Two-Year Follow-Up of Chronic Ischemic Heart Disease Patients in a Specialized Center in Brazil

Eduardo Martelli Moreira1, Henrique Trombini Pinesi1, Eduardo Bello Martins1

  • 1Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP - Brasil.

PubMed

Insights

This study tracked cardiovascular events in chronic ischemic heart disease (CIHD) patients in Brazil over two years. Lowering LDL-cholesterol was the only modifiable factor linked to better outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Clinical Research

Background:

  • Cardiovascular event incidence in chronic ischemic heart disease (CIHD) varies globally.
  • Brazil is underrepresented in international CIHD research.
  • Understanding CIHD patient care and outcomes in Brazil is crucial.

Purpose of the Study:

  • To assess the quality of care for CIHD patients in Brazil.
  • To determine the two-year incidence of cardiovascular events (myocardial infarction, stroke, death) in this population.
  • To identify prognostic factors associated with cardiovascular events in CIHD patients.

Main Methods:

  • A two-year prospective study of 625 CIHD patients at a tertiary public health center in São Paulo, Brazil.
  • Primary endpoint: composite of myocardial infarction, stroke, or death.
  • Statistical analysis to identify independent prognostic factors.

Main Results:

  • The two-year incidence of the primary composite endpoint was 7.05%.
  • Independent predictors for adverse events included older age, history of stroke, and elevated LDL-cholesterol.
  • Significant improvement in angina symptoms (CCS scale) and medication prescription quality was observed.
  • No significant improvement in LDL-cholesterol or blood pressure control.

Conclusions:

  • CIHD patients in Brazil experienced a 7.05% composite event rate over two years.
  • Reducing LDL-cholesterol is the sole identified modifiable risk factor impacting prognosis.
  • Quality of care improved in some aspects, but key risk factor control remains a challenge.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
37
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11